======= PI4KA ======= == Gene Information == * **Official Symbol**: PI4KA * **Official Name**: phosphatidylinositol 4-kinase alpha * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5297|5297]] * **UniProt**: [[https://www.uniprot.org/uniprot/P42356|P42356]] * **Interactions**: [[https://thebiogrid.org/search.php?search=PI4KA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PI4KA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/600286|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a phosphatidylinositol (PI) 4-kinase which catalyzes the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate. The mammalian PI 4-kinases have been classified into two types, II and III, based on their molecular mass, and modulation by detergent and adenosine. The protein encoded by this gene is a type III enzyme that is not inhibited by adenosine. [provided by RefSeq, Sep 2014]. * **UniProt Summary**: Acts on phosphatidylinositol (PtdIns) in the first committed step in the production of the second messenger inositol- 1,4,5,-trisphosphate. {ECO:0000269|PubMed:10101268, ECO:0000269|PubMed:23229899}. |PI3Ka| |PI3 PI4 kinase| |viral replication complex formation and maintenance| |viral replication complex| |1-phosphatidylinositol 4-kinase activity| |multi-organism membrane organization| |viral RNA genome replication| |Golgi-associated vesicle membrane| |multi-organism cellular process| |viral genome replication| |phosphatidylinositol phosphorylation| |lipid phosphorylation| |phosphatidylinositol-mediated signaling| |inositol lipid-mediated signaling| |kinase activity| |phosphatidylinositol biosynthetic process| |phosphatidylinositol metabolic process| |viral life cycle| |lipid modification| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |phospholipid biosynthetic process| |glycerophospholipid metabolic process| |cadherin binding| |phospholipid metabolic process| |glycerolipid metabolic process| |focal adhesion| |organophosphate biosynthetic process| |lipid biosynthetic process| |viral process| |symbiotic process| |interspecies interaction between organisms| |membrane organization| |organophosphate metabolic process| |cellular lipid metabolic process| |lipid metabolic process| |phosphorylation| |ATP binding| |intracellular signal transduction| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|-1.87| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-1.72| |[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-1.71| |[[:results:exp95|BI-2536 0.0042μM R03 exp95]]|1.91| |[[:results:exp475|CyclicAMP 200μM R08 exp475]]|1.96| |[[:results:exp107|UMK57 0.6μM R03 exp107]]|2.13| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 464/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|0/1| |bile duct|16/28| |blood|11/28| |bone|16/26| |breast|25/33| |central nervous system|34/56| |cervix|3/4| |colorectal|13/17| |esophagus|7/13| |fibroblast|1/1| |gastric|15/16| |kidney|11/21| |liver|11/20| |lung|51/75| |lymphocyte|11/16| |ovary|22/26| |pancreas|17/24| |peripheral nervous system|6/16| |plasma cell|8/15| |prostate|0/1| |skin|11/24| |soft tissue|6/9| |thyroid|1/2| |upper aerodigestive|11/22| |urinary tract|23/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1138 * **Expression level (log2 read counts)**: 8.08 {{:chemogenomics:nalm6 dist.png?nolink |}}